Heart Test Laboratories Stock Investor Sentiment

HSCS Stock  USD 3.92  0.24  5.77%   
Slightly above 54% of Heart Test's investor base is interested to short. The analysis of overall sentiment of trading Heart Test Laboratories stock suggests that many investors are impartial at this time. Heart Test's investing sentiment can be driven by a variety of factors including economic data, Heart Test's earnings reports, geopolitical events, and overall market trends.

Comfort Level 46

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Heart Test's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Heart Test Laboratories.

Heart Historical Sentiment

Although Heart Test's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Heart, such as negative comments on social media and news outlets, may cause fear in the market and push Heart Test's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Heart.

Heart Test Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Heart Test can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Heart Test's Stock prices. Below is the latest headlines and news related to Heart Test Laboratories Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Heart Test that are available to investors today. This information is accessible both publicly - through Heart Test's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Heart-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Heart Test news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heart Test relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heart Test's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heart Test alpha.

Heart Largest EPS Surprises

Earnings surprises can significantly impact Heart Test's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-14
2024-01-31-0.06-0.030.0350 
2023-12-14
2023-10-31-0.12-0.16-0.0433 
2023-07-19
2023-04-30-0.16-0.21-0.0531 
2022-12-15
2022-10-31-0.33-0.220.1133 
2025-03-13
2025-01-31-3-2.570.4314 
2024-07-17
2024-04-30-3-18.81-15.81527 
View All Earnings Estimates
3 days ago at news.google.com         
Abbott Laboratories Stock Q2 Beat Masks Challenges from COVID Test Decline, Tariffs, and China Press...
Google News at Macroaxis
few days ago at finance.yahoo.com         
Micropolis Establishes Strategic Partnership with Hader Security and Communication Systems
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Danielle Watson of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Heart Test Laboratories Updates Bylaws to Align with Texas Law - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
MorningStar Laboratories A Vascular Health Breakthrough with Partnerships Driving Growth - AInvest
Google News at Macroaxis
over a month ago at gurufocus.com         
HeartSciences Gains FDA Breakthrough Status for AI ECG Algorithm HSCS Stock News
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences P...
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
HeartSciences Strengthens IP Portfolio with New Patent Grant HSCS Stock News
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
Google News at Macroaxis
over a month ago at gurufocus.com         
HeartSciences Secures First Client for MyoVista Insights in the UK HSCS Stock News
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
HeartSciences Signs First MyoVista Insights Platform Customer,
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
Virax Biolabs Group Stock Price Up 2 percent Heres What Happened - Defense World
Google News at Macroaxis
over two months ago at gurufocus.com         
HeartSciences CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May ...
Gurufocus Stories at Macroaxis
over two months ago at finance.yahoo.com         
HeartSciences CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2...
Yahoo News
over two months ago at gurufocus.com         
HeartSciences to Host Investor Webinar and QA on Wednesday May 14, 2025 - Featuring CEO ...
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Heart Test that are available to investors today. This information is accessible both publicly - through Heart Test's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Heart-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Heart Test news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heart Test relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heart Test's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heart Test alpha.

Heart Test Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
HeartSciences Unveils MyoVista Insights Platform HSCS Stock News
05/01/2025
2
HeartSciences to Host Investor Webinar and QA on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
05/08/2025
3
HeartSciences CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May ...
05/20/2025
4
HeartSciences Signs First MyoVista Insights Platform Customer,
05/29/2025
5
HeartSciences Strengthens IP Portfolio with New Patent Grant HSCS Stock News
06/03/2025
6
Heart Test Laboratories Updates Bylaws to Align with Texas Law - TipRanks
07/01/2025
7
Acquisition by Danielle Watson of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3
07/09/2025
8
Abbott Laboratories Stock Q2 Beat Masks Challenges from COVID Test Decline, Tariffs, and China Pressure - CoinCentral
07/18/2025

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.